24/7 Clients Support
- 24/7
Customer Service
- ISO 9001
Certification Company
- WHO-GMP
Certified Company
ENTELIEVA 0.5MG is an Tablet medication used for treatment purposes. It is manufactured by Allieva Pharma Private Limited.
| Brand Name | ENTELIEVA 0.5MG |
|---|---|
| Composition | Entecavir 0.5mg Tablets |
| Manufacturer | Allieva Pharma Private Limited |
| Dosage Form | Tablet |
| Packaging | Btl (30 Tab) |
| Country of Origin | India |
Entecavir 0.5mg Tablets (Entecavir 0.5mg Tablets) is a widely used Tablet medicine manufactured by Allieva Pharma Private Limited. It is commonly prescribed for...
ENTELIEVA 0.5MG (Entecavir 0.5mg Tablet) is an antiviral medicine used for the treatment and long-term management of chronic hepatitis B virus (HBV) infection. It contains Entecavir, a highly effective antiviral agent that helps reduce the multiplication of the hepatitis B virus inside the body. This medicine is commonly prescribed by healthcare professionals to help control viral activity, improve liver health, and reduce the risk of liver-related complications.
Hepatitis B is a serious viral infection that affects the liver and may lead to chronic liver disease, liver damage, cirrhosis, or liver failure if not managed properly. ENTELIEVA 0.5MG works by blocking the replication process of the hepatitis B virus, helping lower the viral load and slowing the progression of the infection.
Entecavir belongs to a class of medicines known as nucleoside analog antiviral agents. It is widely used in modern antiviral treatment protocols because of its effectiveness in controlling chronic hepatitis B infection in adults and eligible patients under medical supervision.
ENTELIEVA 0.5MG is manufactured under strict pharmaceutical quality standards to ensure safety, purity, and consistent therapeutic performance. The medicine is trusted by healthcare professionals for use in hospitals, liver care centers, gastroenterology clinics, and infectious disease treatment programs.
Doctors may prescribe this antiviral tablet for patients with:
• Chronic hepatitis B infection
• Active viral replication
• Liver inflammation related to HBV
• Compensated or certain liver-related conditions caused by hepatitis B
This antiviral medicine helps reduce the activity of the hepatitis B virus and supports long-term liver disease management. Patients using ENTELIEVA 0.5MG may require regular liver function tests, viral load monitoring, and medical checkups during treatment.
ENTELIEVA should only be used under the supervision of qualified healthcare professionals. Patients are advised not to stop treatment suddenly without consulting their doctor, as stopping antiviral therapy abruptly may worsen hepatitis B infection in some cases.
Due to its effectiveness in hepatitis B management and antiviral therapy protocols, ENTELIEVA 0.5MG is widely used as part of advanced liver infection treatment and supportive healthcare programs.
ENTELIEVA 0.5MG (Entecavir 0.5mg Tablet) is mainly used for the treatment and management of chronic hepatitis B virus infection.
ENTELIEVA is primarily used to help manage chronic hepatitis B infection by reducing viral multiplication inside the body.
The medicine helps lower hepatitis B viral load and supports better infection control.
By controlling HBV activity, Entecavir may help reduce the risk of liver damage and long-term liver complications.
ENTELIEVA may help improve liver enzyme levels and reduce inflammation caused by chronic hepatitis B infection.
Doctors may prescribe Entecavir as part of long-term antiviral treatment plans for eligible patients with chronic HBV infection.
In some cases, this medicine may be used in patients with liver-related complications associated with hepatitis B infection under specialist supervision.
Entecavir belongs to a group of medicines known as antiviral nucleoside analogs. It works by blocking the hepatitis B virus from multiplying inside the body.
ENTELIEVA works by:
• Inhibiting viral DNA replication
• Reducing hepatitis B viral activity
• Slowing the spread of infection
• Helping protect liver cells
• Supporting long-term liver health management
This mechanism helps control chronic hepatitis B infection more effectively.
Like other antiviral medicines, ENTELIEVA 0.5MG may cause side effects in some patients. Side effects may vary depending on the patient’s medical condition, treatment duration, and response to therapy.
Some patients may experience mild to moderate headaches during treatment.
Tiredness and reduced energy levels may occur in certain individuals.
Digestive discomfort or nausea may develop during therapy.
Patients may occasionally feel dizzy or lightheaded.
Mild abdominal discomfort or stomach pain may occur.
Difficulty sleeping or disturbed sleep patterns may develop in some cases.
Some patients may experience loose stools or digestive changes during treatment.
Reduced appetite may occur during antiviral therapy.
Although uncommon, some serious side effects may require urgent medical attention.
• Severe weakness
• Difficulty breathing
• Severe allergic reactions
• Yellowing of skin or eyes
• Persistent abdominal pain
• Unusual swelling
• Dark-colored urine
• Severe liver-related symptoms
Patients should immediately consult their healthcare provider if severe symptoms occur during treatment.
The dosage of ENTELIEVA 0.5MG (Entecavir 0.5mg Tablet) should always be determined by a qualified healthcare professional based on the patient’s medical condition and liver health.
Dosage may vary depending on viral activity and liver condition.
Patients with liver-related complications may require close monitoring during treatment.
Earlier antiviral therapies may influence dosage and treatment planning.
Doctors may adjust dosage in patients with kidney-related conditions.
Dosage adjustments may be made depending on viral load reduction and treatment effectiveness.
• Take the tablet exactly as prescribed
• Swallow the tablet whole with water
• Take the medicine regularly for better results
• Do not skip doses
• Do not stop treatment suddenly without medical advice
• Regular liver function and viral load monitoring may be necessary
Patients should always follow the treatment schedule recommended by their healthcare provider.
Before starting treatment, patients should inform their doctor if they have:
• Liver disease
• Kidney problems
• HIV infection
• Previous antiviral treatment history
• Other chronic medical conditions
Patients should also discuss all medicines and supplements they are currently taking to avoid possible drug interactions.
Pregnant or breastfeeding women should use this medicine only if recommended by a healthcare professional.
• Store in a cool and dry place
• Protect from direct sunlight and moisture
• Keep out of reach of children
• Store at recommended room temperature
• High-quality antiviral formulation
• Trusted hepatitis B treatment support
• Effective viral replication control
• Reliable pharmaceutical manufacturing standards
• Suitable for long-term antiviral therapy
• Used in advanced liver infection management programs
It is mainly used for the treatment and long-term management of chronic hepatitis B virus infection.
Entecavir is an antiviral medicine used to reduce hepatitis B viral replication inside the body.
The medicine helps control the infection and reduce viral activity, but treatment outcomes vary depending on the patient’s condition.
No, patients should never stop treatment without consulting their doctor because sudden discontinuation may worsen hepatitis B infection.
Yes, doctors usually recommend regular liver function tests and viral load monitoring.
Yes, dizziness and headache are possible side effects in some patients.
Yes, this medicine should always be used under the supervision of qualified healthcare professionals.
By reducing hepatitis B viral activity, the medicine may help support long-term liver health management.